Written By: Michael Vale, Health Content Writer
Medically Reviewed By: Cynthia Gavilanes, PA-C, Board-Certified Physician Assistant
Last Reviewed: August 6, 2026
Before a good clinic writes a peptide prescription, it asks for blood work. Lab testing is the step that shows your provider whether a peptide is safe for you, which one fits your goals, and where to set your starting dose. Most people focus on the results and skip past the testing. The testing is what makes the results possible. Here’s what peptide therapy lab work covers, why each marker earns its place, and how to walk into your first visit ready.
Peptide therapy lab work is a set of blood tests done before treatment begins. A typical panel checks kidney and liver function, blood counts, cholesterol, blood sugar, and a handful of hormones. Those results give your clinician a baseline, flag anything that rules a peptide out, and shape both your starting dose and how you get monitored later.
At Revive 365 Wellness, the first appointment at our health and wellness clinic in Weston, FL is built around that baseline rather than around a product.
Why do peptide clinics check your blood first?
Because peptides act like signals inside your body, not gentle vitamins. They work directly on your hormonal and metabolic systems, so a provider who prescribes without a baseline is working half blind.
Blood work answers three questions before you inject anything. Can your kidneys and liver handle a new compound? Are there hormone imbalances behind the symptoms you want to treat? Is there a reason a specific peptide is a poor fit for you? Skip that picture, and even a well-chosen peptide can behave in ways no one planned for.
The core peptide therapy lab panel
Most clinics start with the same core set, then add tests based on your goals.
A comprehensive metabolic panel, or CMP, checks kidney and liver function, electrolytes, and blood sugar in a single draw. It is the broad look at how your organs are doing before anything starts.
A complete blood count, or CBC, reads your red cells, white cells, and platelets. It screens for anemia, infection, and other issues that could complicate a new protocol.
A lipid panel measures cholesterol and triglycerides. Several peptides, including GLP-1 medications, change how your body handles fats, so a starting number makes later shifts readable.
I’ll be honest about something I got wrong early on. I used to think more markers always meant better care. They don’t. Ordering tests no one plans to act on just adds noise, not safety. The right panel is the one matched to your peptide and your history, with nothing padded on for show.
Hormone tests: IGF-1, thyroid, and sex hormones
Hormones set the stage for how peptides perform, so most intake panels read them closely. That overlap is why hormone and peptide therapy often sit side by side in the same plan.
IGF-1 is the marker to watch with growth hormone peptides like sermorelin or ipamorelin. It reflects how much growth hormone your body is making and responding to, and it is how a provider sets your dose and tracks your response over time.
Thyroid comes next. A simple thyroid screen often starts with TSH, with free T4 and T3 added when the picture needs filling in. This matters for a plain reason. An undiagnosed thyroid problem can copy the exact symptoms you hope a peptide will fix.
Sex hormones such as testosterone, estrogen, and DHEA round out the read. They drive energy, body composition, mood, and recovery. When someone comes in for fat loss or muscle support, a gap in this group can flatten the results, so it is better found on day one.
What changes for GLP-1 and weight-loss peptides
GLP-1 medications need two checks the others don’t lean on as hard: thyroid history and kidney function.
On thyroid, these medications carry a boxed warning tied to a rare thyroid tumor seen in animal studies. They are not for people with a personal or family history of medullary thyroid carcinoma or the inherited syndrome MEN 2.
This is where I’ll push back on the internet a little. That warning is narrower than the headlines suggest. It points to one uncommon cancer type and a specific genetic syndrome, not to routine thyroid conditions like well-managed hypothyroidism, and large human studies have not confirmed the tumor signal that animal data first raised. That is not a reason to wave off your history. Your clinician still reviews it, and the warning stands. It is a reason to ask specific questions instead of assuming any thyroid note on your chart closes the door.
Kidney function gets the second look, and this is where living in South Florida actually matters. GLP-1 side effects like nausea, vomiting, and diarrhea can pull fluid out of you, and that dehydration can strain the kidneys. When you are active outdoors most of the year in Broward County heat, that risk is not abstract. A baseline creatinine and eGFR, both part of the core panel, give your provider a reference point before you start and something to compare against if a rough week hits. Our GLP-1 weight-loss program folds these checks into intake for that reason.
What is HbA1c, and why does it guide your plan?
HbA1c is your average blood sugar over roughly the past three months. Below 5.7 percent reads as normal, 5.7 to 6.4 percent sits in the prediabetes range, and 6.5 percent or higher points to diabetes.
For peptides, this number does real work. It helps a provider decide how fast to raise a GLP-1 dose. Someone with a higher HbA1c and more insulin resistance may do better with a slower ramp and extra support along the way. Many general practices stop at fasting glucose. Peptide-focused clinics often add fasting insulin, because the two together show insulin resistance that glucose alone can miss.
How recent do your labs need to be in 2026?
Most clinics want results from the last 90 days. Some accept up to six months for a healthy patient with a stable history. Older than that, expect a fresh draw before anyone writes a prescription.
This is not red tape. Your metabolic and hormone status can move within months, especially after a diet change, a new medication, or a stretch of illness or heavy stress. Recent numbers also make your first visit faster, since your provider can read and act in the same appointment.
What ongoing lab monitoring looks like
Testing does not stop once you start. Rechecks are a normal part of responsible peptide care.
Most providers repeat labs around the three month and six month marks, then at a steady interval after that. For GLP-1 patients, kidney response and lipids are the usual things to watch. For growth hormone peptide patients, IGF-1 stays under close watch so levels hold in a safe, useful range.
What it means when a clinic skips lab work
If a clinic will hand you a prescription with no labs at all, treat it as a warning sign.
A quick form with no blood work behind it is not a faster service. It is an incomplete medical process. Going without labs does not make a prescription illegal, but it does make it less safe, because your provider is deciding without knowing your thyroid status, kidney function, or blood sugar. A clinic that asks for real data is showing you how it plans to treat you. It also helps to know the clinical team reading your results, not just the list of tests.
How to prepare for your first peptide consultation
A little prep makes the first visit smoother.
Ask your primary care provider for your most recent bloodwork before you come in. If it is more than 90 days old, check whether the clinic wants a fresh panel. Fast for at least eight hours before any draw that includes glucose, insulin, or lipids, since food and coffee both skew those numbers. Water is fine. Bring a full list of your medications and supplements, because several of them interact with peptide pathways and can change your dose.
Some patients also pair peptides with skin treatments like microneedling, which carries its own prep steps worth raising in the same visit.
Peptide therapy lab work is the foundation, not the formality. The right tests, read by a provider who knows your history, are what turn a prescription into a plan that fits you. If you are weighing your options in South Florida, our peptide therapy services start with exactly this baseline. The way this guide is organized, so each question stands on its own, reflects input from an outside marketing team that supports the site.
FAQs
What lab work do you need before starting peptide therapy?
Most clinics run a core set: a comprehensive metabolic panel for kidney and liver function, a complete blood count, a lipid panel, blood sugar markers like HbA1c, and hormones such as IGF-1 and TSH. Growth hormone peptides lean on IGF-1, while GLP-1 medications add thyroid history and kidney checks. Most results need to be from the last 90 days.
Do you have to fast before peptide therapy lab work?
Yes, for part of it. Fast at least eight hours before any draw that includes glucose, insulin, or a lipid panel, because food and coffee change those results. Water is fine and makes the draw easier. Hormone and thyroid tests are less sensitive to fasting, but clinics usually batch everything into one morning draw, so plan to arrive fasted.
How recent do your labs need to be?
Most clinics accept results from the last 90 days, and some allow up to six months for a stable, healthy patient. Beyond that, expect a fresh panel, since your hormone and metabolic numbers can shift within months. If you have had a major health change, a new medication, or an illness since your last draw, redo the core tests no matter the date.
Which labs matter most for GLP-1 or weight-loss peptides?
Thyroid history and kidney function. GLP-1 medications carry a boxed warning about a rare thyroid tumor, so a personal or family history of medullary thyroid carcinoma or MEN 2 rules them out. Kidney markers like creatinine and eGFR matter because the digestive side effects can cause dehydration. HbA1c and fasting insulin help set how quickly the dose goes up.
How often are labs repeated during peptide therapy?
Most protocols recheck around three months and six months, then at a steady interval. GLP-1 patients usually have kidney response and lipids tracked, and growth hormone peptide patients have IGF-1 watched to keep it in a safe range. Monthly full panels are not standard, so be cautious if a clinic pushes them without a specific reason.
Are at-home finger-prick kits accurate enough for peptide therapy?
For some markers they are reasonable, but for the decisions that set your protocol they are not the standard. Finger-prick samples work for at-a-glance trends on things like HbA1c, though small sample volumes vary more than a standard blood draw. For your baseline and dosing, a venous draw at an accredited lab is what most providers want. At-home kits are best for tracking between formal visits.
What if a peptide clinic does not require any labs at all?
Treat it as a reason to look elsewhere. A clinic that skips baseline blood work is putting speed ahead of safety, or working outside normal medical practice. Even high-volume telehealth should ask for a basic intake and recent labs. If the entire process is a short form and a next-day shipment, that is a safety flag, not convenience.
Cynthia “Cyndi” Gavilanes, PA-C, is a board-certified Physician Assistant and co-founder of Revive 365 Wellness in Weston, FL. She blends aesthetic expertise with a holistic care philosophy, working across hormone therapy, sexual health, weight management, and advanced aesthetic procedures. With more than three decades of combined clinical experience alongside co-founder Tracee Block-Trapanese, Cyndi delivers safe, personalized, evidence-based care that helps clients look and feel their best.